Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cell Point (India)NSE:CELLPOINT -4.17%67 Debt-to-Equity is 1.04 as of Mar. 2026, which is 61% below its 10-year median of 2.66. GuruFocus rates NSE:CELLPOINT with a GF Score™ of 67/100 and a GF Value™ of ₹35.03 (Significantly Undervalued). The stock has 10 warning signs investors should review. Among 1,024 Retail - Cyclical companies, Cell Point (India) ranks worse than 70.51% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Cell Point (India)'s Debt-to-Equity or its related term are showing as below:
NSE:CELLPOINT'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.61 Med: 2.66 Max: 3.87
Current: 1.04
During the past 7 years, the highest Debt-to-Equity Ratio of Cell Point (India) was 3.87. The lowest was 0.61. And the median was 2.66.
NSE:CELLPOINT's Debt-to-Equity is ranked worse than 70.51% of 1024
companies
in the Retail - Cyclical industry
Industry Median: 0.56
vs NSE:CELLPOINT: 1.04
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Cell Point (India) Debt-to-Equity Related Terms
Cell Point (India) Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Cell Point (India)'s Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:CELLPOINT vs CASY, WSM, ULTA: Debt-to-Equity Comparison
For the Specialty Retail subindustry, Cell Point (India)'s Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cell Point (India) Debt-to-Equity vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Cell Point (India)'s Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Cell Point (India)'s Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cell Point (India) (NSE:CELLPOINT) has a Debt-to-Equity of 1.04 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Cell Point (India) and its competitors. This is 61% below median its historical median of 2.66. Over the past decade, Cell Point (India)'s Debt-to-Equity has ranged from 0.61 to 3.87. According to the industry distribution chart, Cell Point (India) ranks #722 out of 1024 companies in the Retail - Cyclical industry, placing it in the top 70.5%.
Is Cell Point (India)'s Debt-to-Equity too high?
Cell Point (India)'s current Debt-to-Equity of 1.04 is 61% below median its 10-year median of 2.66. Over the past 10 years, this metric has ranged from a low of 0.61 to a high of 3.87. The Retail - Cyclical industry median Debt-to-Equity is 0.56. Cell Point (India)'s value of 1.04 is 85.7% above this industry median. Based on the distribution chart, Cell Point (India) ranks #722 out of 1024 companies in the Retail - Cyclical industry, which is below the industry midpoint. Overall, Cell Point (India) has a GF Score™ of 67/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cell Point (India)'s Debt-to-Equity compare to CASY and WSM?
According to the Retail - Cyclical industry distribution chart, Cell Point (India) ranks #722 out of 1024 companies for Debt-to-Equity. This places Cell Point (India) in the lower half of its industry. The industry median Debt-to-Equity is 0.56. Cell Point (India)'s value of 1.04 is 85.7% above this benchmark. Historically, Cell Point (India)'s own Debt-to-Equity has ranged from 0.61 to 3.87 over the past decade. While the company's 10-year median is 2.66 vs. the industry median of 0.56, Cell Point (India) has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Retail - Cyclical company?
The median Debt-to-Equity among Retail - Cyclical companies is 0.56, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cell Point (India)'s current Debt-to-Equity of 1.04 is 85.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Cell Point (India) and its competitors. For the Retail - Cyclical industry, the median Debt-to-Equity is 0.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cell Point (India)'s current Debt-to-Equity is 1.04, which is 61% below median its own 10-year median of 2.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cell Point (India) stock overvalued right now?
Based on GuruFocus' analysis, Cell Point (India) (NSE:CELLPOINT) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹35.03, compared to a current price of ₹17.25 — trading 50.8% below its estimated fair value. The current Debt-to-Equity is 1.04, which is 61% below median its 10-year median of 2.66 and 85.7% above the Retail - Cyclical industry median of 0.56. Cell Point (India)'s overall GF Score™ is 67/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Cell Point (India) (NSE:CELLPOINT), the current Debt-to-Equity is 1.04 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cell Point (India) (NSE:CELLPOINT) Overvalued in 2026?
Based on GuruFocus' analysis, Cell Point (India) stock appears to be undervalued.
The current stock price of ₹17.25 is trading 50.8% below its estimated GF Value™ of ₹35.03.
GuruFocus considers Cell Point (India) to be Significantly Undervalued.
Key valuation signals for NSE:CELLPOINT:
Debt-to-Equity: 1.04 (61% below median its 10-year median of 2.66)
GF Value™: ₹35.03 vs. price of ₹17.25 (50.8% below fair value)
Industry Position: 85.7% above the Retail - Cyclical median (#722 of 1024)
No single metric tells the full story. See the NSE:CELLPOINT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cell Point (India) Ltd is engaged in multi-brand retail selling of smartphones, tablets, mobile accessories, and mobile-related products of various brands such as Apple, Samsung, Oppo, Realme, Nokia, Vivo, Xiaomi, Nokia, Redmi, Techno, One Plus, etc. It is also engaged in retail selling of consumer durable electronics goods, smart televisions, smart watches, and air conditioners of various brands such as Xiaomi, Realme, and One Plus among others. The company operates in a single segment and derives revenue from its operations in India.
67GF Score
Get the complete analysis for NSE:CELLPOINT
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:CELLPOINT has been successfully added to your 
